HeartWare International (NASDAQ:HTWR) recently announced that it has acquired CircuLite, a company that has pioneered the partial-assist approach of mechanical circulatory support with its SYNERGY Circulatory Support System for the treatment of heart failure for patients who don't respond to traditional therapy and who are not sick enough for inotropes or a full-support bed.
I believe that HeartWare's CircuLite acquisition will tremendously strengthen its product pipeline and strongly complement its HVAD and MVAD product line. Moreover,...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|